To screen or not to screen for medullary thyroid cancer? This is (yet) the question. An illustrative case.

Atti della Accademia Peloritana dei Pericolanti - Classe di Scienze Medico-Biologiche

article

Rosaria Ruggeri¹  Luca Giovannella²  Francesco Trimarchi³  Alfredo Campennì⁴ 

[1] Department of Clinical and Experimental Medicine, University of Messina;Department of Nuclear Medicine and Thyroid Centre, Oncology Institute of Southern Switzerland;at the University of Messina;Department of Biomedical and Dental Sciences, Unit of Nuclear Medicine, University of Messina

关键词: medullary thyroid cancer;    calcitonin;    thyroid nodules;   

DOI  :  10.6092/1828-6550/APMB.106.2.2018.A1

学科分类：农业科学（综合）

来源: Accademia Peloritana dei Pericolanti

【 摘 要 】

Medullary thyroid cancer (MTC) is a rare disease, often displaying an aggressive behavior and a poor prognosis. Serum calcitonin represents the most sensitive marker of MTC and its routine measurement in patients with thyroid nodules allows early detection of occult MTC and appropriate surgical cure.Here we report on a 55-yr-old woman with a long-standing goiter, autonomously functioning thyroid nodules and subclinical thyrotoxicosis, who was diagnosed with MTC at an early stage by means of calcitoninscreening. This rare case highlights the importance of performing routine calcitonin measurementin thyroid nodules.

【 授权许可】

CC BY